Biden’s Prostate Cancer Likely Grew Undetected for Years, Experts Say

Medically reviewed by Carmen Pope, BPharm. Last updated on May 23, 2025.

By I. Edwards HealthDay Reporter

FRIDAY, May 23, 2025 — Former President Joe Biden's prostate cancer diagnosis has drawn attention to screening guidelines for older men.

When Biden, 82, was diagnosed last week, his cancer had already spread to his bones. His last prostate screening was more than a decade ago.

“President Biden’s last known PSA was in 2014," a spokesperson for the former president said this week. "Prior to Friday, President Biden had never been diagnosed with prostate cancer.”

PSA is an abbreviation for prostate-specific antigen test, which looks for a protein made by the prostate. High levels can be a sign of cancer, but the test can also give false positives, NBC News reported.

That means it may suggest cancer is present when it is not. Because of this, and because older men often die of other causes, the U.S. Preventive Services Task Force does not recommend PSA testing for men 70 and older.

Biden’s late-stage diagnosis has led to questions about whether his cancer developed quickly, NBC News said, or went unnoticed during his presidency.

Experts say advanced prostate cancer can sometimes grow quietly for years before being detected.

Dr. Ezekiel Emanuel, an oncologist who advised Biden’s COVID-19 transition team, said on MSNBC that the cancer had likely been “growing there and spreading” for a long time.

Dr. William Dahut, chief scientific officer for the American Cancer Society, told NBC News, “We definitely would anticipate that he has had prostate cancer for many, many years."

While most prostate cancers grow slowly, some rare types can become aggressive quickly.

In Biden’s case, doctors say the cancer is serious but still treatable, though not curable.

President Donald Trump, 78, had a PSA test earlier this year, according to medical records that have been made public — meaning some doctors are still choosing to screen older patients for prostate cancer.

Sources

  • NBC News, May 20, 2025
  • Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

    Source: HealthDay

    Read more

    Disclaimer

    Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

    The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

    Popular Keywords